Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins
- PMID: 37465805
- PMCID: PMC10350714
- DOI: 10.7759/cureus.40552
Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins
Abstract
The use of statins may be associated with muscle-related side effects ranging from myalgia to rhabdomyolysis. A rare adverse effect is statin-induced anti-hydroxy-3-methyl-glutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myositis, which may develop after exposure to statins due to autoantibodies against HMG-Co-A reductase. We present the case of a 76-year-old male who developed progressive muscle weakness three years after exposure to statins. He had significantly elevated creatine kinase (CK) levels, despite the discontinuation of statins three years prior. He complained of generalized muscle weakness, and examination revealed reduced strength, especially in the proximal musculature. MRI revealed inflammatory myositis of the medial and posterior compartments of bilateral thighs. Autoimmune workup was positive for anti-HMG-CoA reductase antibodies. Muscle biopsy showed endomysial inflammation with fibrosis and fat replacement, suggesting chronic but active myositis. A diagnosis of chronic anti-HMGCR necrotizing myositis was made. The patient was started on oral prednisone and methotrexate with improvement in symptoms and CK levels. This case highlights a chronic form of a rare cause of myositis that may be a challenge to diagnose given the remote exposure to statins.
Keywords: anti-hmgcr; myopathy; myositis; necrotizing myositis; statins.
Copyright © 2023, Salar et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Dysphagia: A Case Report of an Atypical Presentation of Statin-Induced Necrotizing Myositis.Cureus. 2023 Aug 16;15(8):e43587. doi: 10.7759/cureus.43587. eCollection 2023 Aug. Cureus. 2023. PMID: 37719573 Free PMC article.
-
Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.Drug Discov Ther. 2018;12(5):315-317. doi: 10.5582/ddt.2018.01049. Drug Discov Ther. 2018. PMID: 30464165
-
Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report.J Community Hosp Intern Med Perspect. 2019 Feb 11;9(1):33-35. doi: 10.1080/20009666.2019.1571882. eCollection 2019. J Community Hosp Intern Med Perspect. 2019. PMID: 30788073 Free PMC article.
-
Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.Muscle Nerve. 2013 Oct;48(4):477-83. doi: 10.1002/mus.23854. Epub 2013 Aug 30. Muscle Nerve. 2013. PMID: 23519993 Review.
-
Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.Expert Rev Clin Immunol. 2018 Mar;14(3):215-224. doi: 10.1080/1744666X.2018.1440206. Epub 2018 Feb 23. Expert Rev Clin Immunol. 2018. PMID: 29473763 Free PMC article. Review.
Cited by
-
Advances in Small Molecular Agents against Oral Cancer.Molecules. 2024 Apr 3;29(7):1594. doi: 10.3390/molecules29071594. Molecules. 2024. PMID: 38611874 Free PMC article. Review.
-
Dysphagia: A Case Report of an Atypical Presentation of Statin-Induced Necrotizing Myositis.Cureus. 2023 Aug 16;15(8):e43587. doi: 10.7759/cureus.43587. eCollection 2023 Aug. Cureus. 2023. PMID: 37719573 Free PMC article.
References
-
- Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. Cohen JD, Brinton EA, Ito MK, Jacobson TA. https://www.sciencedirect.com/science/article/abs/pii/S1933287412000827. J Clin Lipidol. 2012;6:208–215. - PubMed
-
- Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B. https://pubmed.ncbi.nlm.nih.gov/16453090/ Cardiovasc Drugs Ther. 2005;19:403–414. - PubMed
-
- Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child. Mohassel P, Foley AR, Donkervoort S, Fequiere PR, Pak K, Bönnemann CG, Mammen AL. https://doi.org/10.1002/mus.25567. Muscle Nerve. 2017;56:1177–1181. - PubMed
-
- Statin muscle-related adverse events. https://www.uptodate.com/contents/statin-muscle-related-adverse-events https://www.uptodate.com/contents/statin-muscle-related-adverse-events
-
- 224th ENMC international workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Allenbach Y, Mammen A, Benveniste O, Stenzel W. https://www.nmd-journal.com/article/S0960-8966(17)31207-5/fulltext. Neuromuscul Disord. 2018;28:87–99. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials